Anterogen.Co.Ltd Cash Flow-to-Debt Ratio
Anterogen.Co.Ltd cash flow-to-debt ratio. Anterogen.Co.Ltd (065660) has a Cash Flow-to-Debt Ratio of 0.20x as of September 2025, meaning its operating cash flow of ₩281.98 Million could theoretically repay 0% of its total liabilities (₩1.40 Billion) in one year. Check 065660 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Anterogen.Co.Ltd (2014–2024)
Cash flow-to-debt ratio of Anterogen.Co.Ltd from 2014 to 2024. Historical debt coverage capacity for Anterogen.Co.Ltd across 11 annual periods. Check 065660 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Anterogen.Co.Ltd Cash Flow-to-Debt Ratio by Year (2014–2024)
Anterogen.Co.Ltd cash flow-to-debt ratio by year from 2014 to 2024. Year-by-year debt coverage analysis for Anterogen.Co.Ltd. For the full cash flow conversion analysis, see how efficiently does Anterogen.Co.Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.15x | ₩-860.38 Million | ₩5.87 Billion | ▼ -47.4% |
| 2023 | -0.10x | ₩-1.99 Billion | ₩19.99 Billion | ▲ +12.7% |
| 2022 | -0.11x | ₩-1.98 Billion | ₩17.34 Billion | ▲ +25.8% |
| 2021 | -0.15x | ₩-3.05 Billion | ₩19.83 Billion | ▲ +54.3% |
| 2020 | -0.34x | ₩-4.41 Billion | ₩13.14 Billion | ▼ -230.2% |
| 2019 | -0.10x | ₩-1.65 Billion | ₩16.20 Billion | ▼ -206.9% |
| 2018 | -0.03x | ₩-1.50 Billion | ₩45.37 Billion | ▼ -200.8% |
| 2017 | 0.03x | ₩379.21 Million | ₩11.53 Billion | ▲ +135.3% |
| 2016 | -0.09x | ₩-130.65 Million | ₩1.40 Billion | ▼ -120.4% |
| 2015 | 0.46x | ₩844.49 Million | ₩1.85 Billion | ▲ +168.1% |
| 2014 | -0.67x | ₩-1.01 Billion | ₩1.51 Billion | — |